Invasive rhino-orbital-cerebral aspergillosis in an immunocompetent patient.

Abstract

INTRODUCTION:

Rhino-orbital-aspergillosis (ROA) is a rare but serious disease in immunocompetent patients. Diagnosis is often delayed due to the absence of specific clinical symptoms. We describe the case of a patient who presented initially with ROA which spread progressively to the right ethmoid-sphenoid sinuses and then to the brain.

OBSERVATION:

A 61-year-old patient with a history of well-controlled diabetes presented with a sudden severe decrease in right visual acuity. Cerebral MRI showed the presence of an infiltrate in the right orbital apex extending to the homolateral cavernous sinus without any cerebral involvement. A diagnosis of right orbital myositis was made and corticosteroid therapy was started. His symptoms worsened progressively leading to quasi-blindness. A new MRI showed the development of right sphenoid-ethmoid osteolytic lesions. A fungal aetiology was suspected and tests for fungal biomarkers found a β-(1-3)-D-glucan level of 99pg/ml but negative galactomannan. An ethmoid biopsy was performed for histological and mycological investigations, including the detection of Aspergillus DNA by qPCR. qPCR was positive and culture resulted in the isolation of multi-sensitive Aspergillus fumigatus. Treatment was initiated with voriconazole. Due to persistence of blindness and the appearance of a lesion extending to the right frontal lobe, surgical excision was performed followed by antifungal treatment for a total duration of 1year. The patient is currently stable, but has persistence of blindness in the right eye.

CONCLUSION:

Invasive ROA is a rare but serious disease in immunocompetent patients which should be evoked in the differential diagnosis of a tumour or vasculitis. Early diagnosis is essential for optimal management.

• Authors: J Leroy, F Vuotto, V Le, M Cornu, N François, L Marceau, C Fichet, S Loridant, B Sendid
• Journal: Journal de mycologie medicale (J Mycol Med) Vol. 30 Issue 3 Pg. 101002 (Sep 2020) ISSN: 1773-0449 [Electronic] France
• PMID: 32507472 (Publication Type: Case Reports, Journal Article)
• Copyright: Copyright © 2020. Published by Elsevier Masson SAS.

Chemical References

• Antifungal Agents
• Voriconazole

Topics

• Antifungal Agents (therapeutic use)
• Aspergillosis (diagnosis, drug therapy, microbiology)
• Aspergillus fumigatus (isolation & purification)
• Blindness (diagnosis, microbiology)
• Central Nervous System Fungal Infections (complications, diagnosis, drug therapy, microbiology)
• Diabetes Complications (drug therapy, microbiology)
• Eye Infections, Fungal (complications, diagnosis, drug therapy, microbiology)
• Humans
• Immunocompetence
• Invasive Fungal Infections (diagnosis, drug therapy, microbiology)
• Male
• Middle Aged
• Neuroaspergillosis (complications, diagnosis, drug therapy, microbiology)
• Orbital Diseases (diagnosis, drug therapy, microbiology)
• Rhinitis (complications, diagnosis, drug therapy, microbiology)
• Voriconazole (therapeutic use)